// App-Quantinova.ai

e22017 : Analysis of circulating tumor cells for monitoring treatment response in triple-negative breast cancer.

Researchers

Presenter

  • Arturo Ramirez

Principal Investigators

  • Daniel Campton

  • Jackie L. Stilwell

  • Elisabeth Mahen

  • C. Anthony Blau

  • Eric Peter Kaldjian

Medical Centers

  • RareCyte Inc., Seattle, WA

  • Center for Cancer Innovation, University of Washington, Seattle, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Epidermal growth factor receptor

  • Epithelial Cell Adhesion Molecule

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved